N-(7-Chloro-2,3-dihydro-1H-inden-4-yl)-5-methylpyrrolidin-2-imine Hydrochloride

ID: ALA3408289

Chembl Id: CHEMBL3408289

PubChem CID: 89964710

Max Phase: Preclinical

Molecular Formula: C14H18Cl2N2

Molecular Weight: 248.76

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1CC/C(=N/c2ccc(Cl)c3c2CCC3)N1.Cl

Standard InChI:  InChI=1S/C14H17ClN2.ClH/c1-9-5-8-14(16-9)17-13-7-6-12(15)10-3-2-4-11(10)13;/h6-7,9H,2-5,8H2,1H3,(H,16,17);1H

Standard InChI Key:  CDWAMZFJYGYWGZ-UHFFFAOYSA-N

Associated Targets(Human)

ADRA2A Tclin Adrenergic receptor alpha-2 (812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nisch Nischarin (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 248.76Molecular Weight (Monoisotopic): 248.1080AlogP: 3.82#Rotatable Bonds: 1
Polar Surface Area: 24.39Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.35CX LogP: 3.70CX LogD: 2.72
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.80Np Likeness Score: -0.61

References

1. Gasparik V, Greney H, Schann S, Feldman J, Fellmann L, Ehrhardt JD, Bousquet P..  (2015)  Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.,  58  (2): [PMID:25521963] [10.1021/jm501456p]

Source